EIO Biomedical Preventing surgical adhesions safely

This project has received funding  from the European Union's Horizon 2020 research and innovation programme under grant agreement no 827874

Surgical adhesions are one of the most pressing unmet needs in surgery today. Post-surgical adhesions form at high rates causing severe complications. The impact on health systems is estimated at billions of dollars yearly.

​

EIO Biomedical’s solution –

an Innovative coagulation factors concentrate [Extrinsic system concentrate (ESC)]

• Our solution is a spray containing critical blood clotting proteins

• Can be used in both laparoscopic and open surgeries

• These proteins leads to targeted clotting at the wound site, and change the way the Fibrin network is formed – cross linking Fibrin into a barrier to cells and adhesion formation

Unlike traditional adhesion barriers, the EIO Biomedical solution contains no polymers or zoonotic proteins, greatly reducing the potential for adverse reactions
 

PATENT APPLICATIONS IN MAJOR COUNTRIES

• Composition

• Method of generating the extract

• Method of treating adhesions